Clinical response observed in a phase I study in T cell lymphoma patients treated with anti-CD70 SIMPLE Antibody ARGX-110.

被引：3
|
作者：
Michot, Jean-Marie
Maerevoet, Marie
Aftimos, Philippe Georges
Rottey, Sylvie
Rolfo, Christian Diego
Offner, Fritz
Van Rompaey, Luc
Moshir, Mahan
de Haard, Hans
Silence, Karen
Pauwels, Patrick
Zwaenepoel, Karen
Awada, Ahmad
Bron, Dominique
Ribrag, Vincent
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Ctr Hosp Univ, Ottignies, Belgium
[3] Jules Bordet Canc Inst, Brussels, Belgium
[4] Ghent Univ Hosp, Heymans Inst Pharmacol, Ghent, Belgium
[5] Univ Antwerp Hosp, Phase Early Clin Trials Unit 1, Edegem, Belgium
[6] Univ Ziekenhuis Gent, Ghent, Belgium
[7] arGEN X, Zwijnaarde, Belgium
[8] arGEN X BVBA, Zwijnaarde, Belgium
[9] Univ Antwerp Hosp, Retie, Belgium
[10] UZA, Antwerp, Belgium
[11] Inst Jules Bordet, Brussels, Belgium
[12] Inst Goustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7556
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase 1 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, in Patients with CD20+B-Cell Malignancies Previously Treated with CD20-Directed Antibody Therapy
    Bannerji, Rajat
    Brown, Jennifer R.
    Advani, Ranjana H.
    Arnason, Jon
    O'Brien, Susan M.
    Allan, John N.
    Chavez, Julio C.
    Barnes, Jeffrey A.
    Joyce, Robin
    Ansell, Stephen
    Topp, Max S.
    Adriaens, Lieve
    Ufkin, Melanie
    Kostic, Ana
    Paccaly, Anne
    Gao, Bo
    Trail, Pamela A.
    Lowy, Israel
    Brownstein, Carrie
    BLOOD, 2016, 128 (22)
  • [42] Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
    Advani, Ranjana H.
    Lebovic, Daniel
    Chen, Andy
    Brunvand, Mark
    Goy, Andre
    Chang, Julie E.
    Hochberg, Ephraim
    Yalamanchili, Sreeni
    Kahn, Robert
    Lu, Dan
    Agarwal, Priya
    Dere, Randall C.
    Hsieh, Hsin-Ju
    Jones, Surai
    Chu, Yu-Waye
    Cheson, Bruce D.
    CLINICAL CANCER RESEARCH, 2017, 23 (05) : 1167 - 1176
  • [43] A Phase I Study of Anti-ICOS Antibody MEDI-570 for Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Angioimmunoblastic T-Cell Lymphoma (AITL) (NCI-9930)
    Chavez, Julio C.
    Foss, Francine M.
    William, Basem M.
    Brammer, Jonathan E.
    Smith, Sonali M.
    Prica, Anca
    Zain, Jasmine M.
    Tuscano, Joseph M.
    Glenn, Martha
    Mehta-Shah, Neha
    Wang, Ben X.
    Zantinge, Stephanie
    Wang, Lisa
    Zhang, Ling
    Boutrin, Anmarie
    Zhao, Weiguang
    Cheng, Lily
    Standifer, Nathan
    Carlesso, Gianluca
    Moscow, Jeffrey
    Siu, Lillian
    BLOOD, 2020, 136
  • [44] Phase I Study of Ipilimumab, an Anti-CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
    Ansell, Stephen M.
    Hurvitz, Sara A.
    Koenig, Patricia A.
    LaPlant, Betsy R.
    Kabat, Brian F.
    Fernando, Donna
    Habermann, Thomas M.
    Inwards, David J.
    Verma, Meena
    Yamada, Reiko
    Erlichman, Charles
    Lowy, Israel
    Timmerman, John M.
    CLINICAL CANCER RESEARCH, 2009, 15 (20) : 6446 - 6453
  • [45] Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study
    Martin Sebastian
    Bernward Passlick
    Hilke Friccius-Quecke
    Michael Jäger
    Horst Lindhofer
    Frank Kanniess
    Rainer Wiewrodt
    Eckhard Thiel
    Roland Buhl
    Alexander Schmittel
    Cancer Immunology, Immunotherapy, 2007, 56 : 1637 - 1644
  • [46] A Phase 1 Study of XmAb18968, a CD3-CD38 Bispecific Antibody for the Treatment of Patients with Relapsed/Refractory Acute Leukemia and T Cell Lymphoblastic Lymphoma
    Murthy, Guru Subramanian Guru
    Kearl, Tyce J.
    Cui, Weiguo
    Johnson, Bryon
    Hoffmeister, Karin
    Szabo, Aniko
    Aoki, Kazuhiro
    Harrington, Alexandra M.
    Carlson, Karen
    Michaelis, Laura C.
    Runaas, Lyndsey
    Abedin, Sameem
    Duvall, Adam S.
    Stock, Wendy
    Shah, Bijal D.
    Leonard, Jessica
    Pratz, Keith W.
    Luger, Selina M.
    Badar, Talha
    Baim, Arielle
    Yaghoubi, Shahriar
    Atallah, Ehab L.
    BLOOD, 2021, 138
  • [47] Chimeric anti-CD20 monoclonal antibody (rituximab) plus G-CSF in relapsed B-cell-lymphoma:: A phase I/II clinical trial.
    van der Kolk, LE
    Grillo-López, AJ
    Gerritsen, W
    Jonkhoff, AR
    Baars, J
    van Oers, MHJ
    BLOOD, 1998, 92 (10) : 241B - 241B
  • [48] Multicenter Phase II Study of Mogamulizumab ( KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
    Ogura, Michinori
    Ishida, Takashi
    Hatake, Kiyohiko
    Taniwaki, Masafumi
    Ando, Kiyoshi
    Tobinai, Kensei
    Fujimoto, Katsuya
    Yamamoto, Kazuhito
    Miyamoto, Toshihiro
    Uike, Naokuni
    Tanimoto, Mitsune
    Tsukasaki, Kunihiro
    Ishizawa, Kenichi
    Suzumiya, Junji
    Inagaki, Hiroshi
    Tamura, Kazuo
    Akinaga, Shiro
    Tomonaga, Masao
    Ueda, Ryuzo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (11) : 1157 - +
  • [49] A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin
    Castelletti, D
    Fracasso, G
    Righetti, S
    Tridente, G
    Schnell, R
    Engert, A
    Colombatti, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (02): : 365 - 372
  • [50] A Phase I Study Of Myeloablative Radioimmunotherapy Using Iodine-131 Anti-CD45 Antibody Followed By Autologous Stem Cell Transplantation For High-Risk B-Cell and T-Cell Non-Hodgking Lymphoma and Hodgkin Lymphoma
    Cassaday, Ryan D.
    Press, Oliver W.
    Pagel, John M.
    Rajendran, Joseph G.
    Gooley, Theodore A.
    Fisher, Darrell R.
    Lundberg, Sally J.
    Hedin, Lacey M.
    Shields, Andrew T.
    Green, Damian J.
    Miyaoka, Robert S.
    Appelbaum, Frederick R.
    Gopal, Ajay K.
    BLOOD, 2013, 122 (21)
12345